Hedge Fund - Abrams Capital Management
Teva Pharmaceutical Industries Ltd (TEVA)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2024 - Q1 (2024-03-31) | $0 | 0% | 0 | $12.61 |
| 2 | 2023 - Q4 (2023-12-31) | $62,606,968 | 1.94% | 5,996,836 | $9.34 |
| 3 | 2023 - Q3 (2023-09-30) | $81,257,617 | 2.68% | 7,966,433 | $9.31 |
| 4 | 2023 - Q2 (2023-06-30) | $59,987,240 | 1.72% | 7,966,433 | $8.11 |
| 5 | 2023 - Q1 (2023-03-31) | $70,502,932 | 2.22% | 7,966,433 | $9.89 |
| 6 | 2022 - Q4 (2022-12-31) | $145,307,729 | 5.18% | 15,932,865 | $8.73 |
| 7 | 2022 - Q3 (2022-09-30) | $192,867,000 | 5.56% | 23,899,296 | $8.84 |
| 8 | 2022 - Q2 (2022-06-30) | $180,829,000 | 4.86% | 24,046,356 | $8.71 |
| 9 | 2022 - Q1 (2022-03-31) | $225,795,000 | 5.27% | 24,046,356 | $8.35 |
| 10 | 2021 - Q4 (2021-12-31) | $192,611,000 | 4.22% | 24,046,356 | $9.03 |
| 11 | 2021 - Q3 (2021-09-30) | $234,212,000 | 5.1% | 24,046,356 | $9.36 |
| 12 | 2021 - Q2 (2021-06-30) | $238,059,000 | 5.29% | 24,046,356 | $10.58 |
| 13 | 2021 - Q1 (2021-03-31) | $277,495,000 | 6.24% | 24,046,356 | $11.47 |
| 14 | 2020 - Q4 (2020-12-31) | $232,047,000 | 6.54% | 24,046,356 | $9.58 |
| 15 | 2020 - Q3 (2020-09-30) | $216,658,000 | 6.84% | 24,046,356 | $10.58 |
| 16 | 2020 - Q2 (2020-06-30) | $296,492,000 | 9.58% | 24,046,356 | $11.31 |
| 17 | 2020 - Q1 (2020-03-31) | $215,936,000 | 8.49% | 24,046,356 | $10.25 |
| 18 | 2019 - Q4 (2019-12-31) | $235,654,000 | 7.32% | 24,046,356 | $8.93 |
| 19 | 2019 - Q3 (2019-09-30) | $165,439,000 | 4.63% | 24,046,356 | $7.66 |
| 20 | 2019 - Q2 (2019-06-30) | $166,568,000 | 4.52% | 18,046,356 | $12.06 |
| 21 | 2019 - Q1 (2019-03-31) | $282,967,000 | 7.94% | 18,046,356 | $17.63 |
| 22 | 2018 - Q4 (2018-12-31) | $285,615,000 | 11.8% | 18,522,372 | $20.50 |
| 23 | 2018 - Q3 (2018-09-30) | $420,512,000 | 11.11% | 19,522,372 | $23.22 |
| 24 | 2018 - Q2 (2018-06-30) | $480,153,000 | 13.35% | 19,743,123 | $20.39 |
| 25 | 2018 - Q1 (2018-03-31) | $337,410,000 | 10.57% | 19,743,123 | $19.52 |
| 26 | 2017 - Q4 (2017-12-31) | $374,132,000 | 12.59% | 19,743,123 | $15.04 |
| 27 | 2017 - Q3 (2017-09-30) | $380,580,000 | 14.85% | 21,623,886 | $22.50 |
| 28 | 2013 - Q3 (2013-09-30) | $0 | 0% | 0 | $39.01 |
| 29 | 2013 - Q2 (2013-06-30) | $100,402,000 | 5.8% | 2,561,269 | $38.94 |
| 30 | 2013 - Q1 (2013-03-31) | $101,631,000 | 9.84% | 2,561,269 | $38.59 |
| 31 | 2012 - Q4 (2012-12-31) | $95,638,000 | 8.68% | 2,561,269 | $39.91 |
| 32 | 2012 - Q3 (2012-09-30) | $97,521,000 | 10.19% | 2,355,000 | $40.44 |
| 33 | 2012 - Q1 (2012-03-31) | $106,116,000 | 9.27% | 2,355,000 | $44.59 |
| 34 | 2011 - Q4 (2011-12-31) | $95,048,000 | 7.29% | 2,355,000 | $33.60 |
| 35 | 2011 - Q3 (2011-09-30) | $80,805,000 | 7.07% | 2,171,000 | $35.08 |
The displayed share prices are average quarterly stock market prices.